innovationUTAH.com
Linking Utah's Innovation Community
David Ward, Ph.D., Center for Advanced Nutrition
David C. Ward is a USTAR professor in the Center for Advanced Nutrition. He was appointed as the Deputy Director of the Nevada Cancer Institute in May of 2004. As the Deputy Director, Dr. Ward will work closely with Dr. Nicholas Vogelzang, the Director NVCI, to coordinate the institute's scientific research efforts in Basic Translational research, Population Science and Drug Development. Dr. Ward is internationally recognized for his pioneering research in the fields of molecular cytogenetics, cancer genetics, virology and optical imaging technology. He has received numerous awards, both nationally and internationally, including election to the National Academy of Sciences. He has co-authored over 300 scientific publications and has served on grant review panels in the US, Canada and England for many years. Dr. Ward also co-founded five biotechnology companies, three of which are publicly traded on national stock exchanges.
Dr. Ward earned his B.S. in Microbiology from Memorial University of Newfoundland, Canada; M.Sc. in Biochemistry from the University of British Columbia, Vancouver; and his Ph.D. in Biochemistry from Rockefeller University, New York. After a postdoctoral fellowship at the Imperial Cancer Research Fund in London, England, Dr. Ward joined the faculty of Yale University School of Medicine in 1971, where he remained in the Departments of Genetics and Molecular Biophysics and Biochemistry until his recruitment to NVCI. Specializing in the development of new technologies and the application of new technologies to human health, Dr. Ward will lead projects focused on genetics, proteomics and imaging. The genetics and proteomics projects will be carried out in collaboration with his wife, Dr. Patricia Bray-Ward as well as with other investigators at the NVCI. Genetics projects will include the study of cancer mutations and genetic epidemiology as it relates to the incidence of cancer, genetic predisposition to cancer, and patient response to cancer therapy protocols. Proteomics is focused on the discovery of serum biomarkers for various cancers and chemotherapeutic response serum biomarkers. In addition, Dr. Ward has a strong interest in the development and application of thermal and infrared imaging technologies for cancer imaging.